Scientists from Augusta University, United States showed a potential protective role for cannabidiol (CBD) during Acute Respiratory Distress Syndrome(ARDS) and suggested it could be the treatment for COVID-19. Cannabidiol (CBD) have shown it could reduce the cytokine storm, protecting pulmonary tissues, and re-establish inflammatory homeostasis.

Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA, Hesam Khodadadi, Évila Lopes Salles, Abbas Jarrahi, Fairouz Chibane, Vincenzo Costigliola, Jack C. Yu, Kumar Vaibhav, David C. Hess, Krishnan M. Dhandapani, and Babak Baban Published Online: 2 Sep 2020 https://doi.org/10.1089/can.2020.0043

Acute Respiratory Distress Syndrome (ARDS) is a life-threatening complication that makes patient unable to breathe as their lung become filled with cytokine storm fluid. Using the mice model, the research team from Augusta University, United States, showed cannabidiol (CBD) modulates cytokine storm and showed the possibility to stop COVID-19 complications.

Similarly, University of South Carolina reported tetrahydrocannabinol (THC) suppressed inflammatory cytokines through ARDS induced mice experiement.